top of page
  • Facebook
  • X
  • Instagram
  • LinkedIn
Search

Aegis Capital Corp. announces the hiring of a new Director of Healthcare Research

NEW YORK, NY / ACCESSWIRE / January 6, 2021 / Aegis Capital Corp., - Aegis Capital Corp. (www.aegiscapcorp.com) a full-service wealth management, financial services and investment banking firm is pleased to announce Chrishan Anketell has joined the firm as a Director of Healthcare Research

Chrishan Anketell has extensive experience in sell-side equity and fixed income fundamental analysis covering a wide variety of sectors including Medical Devices, Healthcare Services, Biotech, Cleantech and Technology. Mr. Anketell started his career as a Market Research Associate at FTN Midwest Research and has since worked on several highly ranked equity research teams by Institutional Investor and Starmine. Prior to joining Aegis, Chrishan has worked in the equity research capacity at Dahlman Rose & Company, MKM Partners LLC, Northcoast Research Partners and Roth Capital Partners. Throughout his career, Mr. Anketell has been very successful in building solid relationships with industry specialists through intensive channel checks and weekly conference calls. Chrishan was also responsible for interacting with buy-side clients, interfacing with corporate management teams, organizing and attending non-deal roadshows and conferences, tracking industry data, maintaining company specific financial models and authoring a high-quality research product.


Robert Eide Aegis' CEO commented: "With the addition of Chrishan as a Director of Healthcare Research Aegis continues to expand the scope of our research department. Chrishan's knowledge and experience will be instrumental in helping our clients, issuers and advisors."


Michael Pata Aegis' Head of Business Development commented: "Chrishan is a valuable addition to Aegis Capital's continued effort to expand our research department and we are pleased he has joined our firm. Chrishan's experience, credentials and vast understanding of the healthcare sector will be a complement to our research team."









About Aegis Capital Corporation

Aegis Capital Corporation "Aegis" has been in business for over 35 years catering to the needs of private clients, institutions and corporations. Aegis was founded in 1984 and offers its investment representatives a conflict free service platform and is able to provide a full range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles. Aegis is able to provide quality service through its primary clearing relationship with RBC Correspondent Services whose parent company, Royal Bank of Canada (NYSE:RY), is one of the world's leading diversified financial services companies. Member: FINRA / SIPC


Any questions contact: Michael Pata, Head of Business Development Telephone: 1-212-813-1010 mpata@aegiscap.com www.aegiscapcorp.com


SOURCE: Aegis Capital Corp.

 
 
 

Comments


xlogo-300x54-2.png.pagespeed.ic_.nkzkchnVAG-2-1.png

Founded in 1984, Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Our management is committed to providing the highest level of service to our clients.

Contact Us

1345 Avenue of the Americas, 27th Floor

New York, NY 10105

Phone: (212) 813-1010 | 800-920-2502

Fax: (212) 937-3916

Members of 

FINRA | SIPC | NQX | ARCA
Trades are cleared on a fully disclosed basis and assets are held at RBC and Axos

FINRA Broker Check | Senior Helpline |Clearing Firms Disclosures

Aegis Capital Corporation , All Rights Reserved

 

Brokerage and investment advisory products and services, are offered through Aegis Capital Corp, a member of FINRA and SIPC. Insurance products are made available through, ACC General Agency, a licensed insurance agency. For those persons inquiring from states where a specific associate is not currently securities and/or insurance licensed, the associate will not transact business in that state or provide follow-up individual responses, until after the associate obtains the appropriate registration in the applicable state.

 

The information provided should not be relied upon in isolation for the purpose of making an investment decision. You must also consider the objectives, risks, charges, and expenses associated with an investment service, product or strategy prior to making an investment decision. Prior to making any investment or financial decision, an investor should seek advice from a financial, legal, tax and other professional that consider all of the particular facts and circumstances of an investor’s situation. The opinions expressed and material provided are for information purposes only and is not an offer, recommendation, or solicitation of any product, strategy or transaction. Any views, strategies or products discussed may not be appropriate or suitable for all individuals and are subject to risks.

Investment and insurance products offered are not insured by the FDIC or any other federal government agency, are not deposits or other obligations of, or guaranteed by, a bank or any bank affiliate, and are subject to investment risks, including possible loss of the principal amount invested.

Securities offered through Aegis Capital Corporation, a registered Broker/Dealer. Member: FINRA/SIPC | Investment advisory services offered through Aegis Capital Corporation, an SEC Registered Investment Advisor.

© 2023 Aegis Capital Corporation, All Rights Reserved proudly created by YNotYou Media

bottom of page